Black Diamond Therapeutics (BDTX) Shares Outstanding (2018 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly Shares Outstanding (Entity) came in at $57.3 million in Q1 2026, up 1.1% YoY from $56.7 million in Q1 2025, and little changed on a QoQ basis from $57.1 million in Q4 2025.
Black Diamond Therapeutics (BDTX) Shares Outstanding (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 9 years of Shares Outstanding (Entity) data on file, last reported at $57.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 1.1% year-over-year to $57.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.3 million (up 1.1% YoY) and the FY2025 annual result came in at $57.1 million, up 0.87% from the prior year.
- Shares Outstanding (Entity) held at $57.3 million in Q1 2026, from $57.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $57.3 million in Q1 2026 to a low of $36.3 million in Q1 2022.
- A 5-year average of $48.8 million and a median of $52.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 0.3% — and 2024, when it jumped 54.4%.
- Tracing BDTX's Shares Outstanding (Entity) over 5 years: stood at $36.4 million in 2022, then soared by 41.75% to $51.6 million in 2023, then gained by 9.68% to $56.6 million in 2024, then grew by 0.87% to $57.1 million in 2025, then increased by 0.29% to $57.3 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $57.3 million (Q1 2026), $57.1 million (Q4 2025), and $56.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Black Diamond Therapeutics | 125.92 Mn | 15.42 Mn | - | 57.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.37 Mn |
| Mar 31, 2026 | 57.23 Mn |
| Dec 31, 2025 | 56.87 Mn |
| Sep 30, 2025 | 56.93 Mn |
| Jun 30, 2025 | 56.80 Mn |
| Mar 31, 2025 | 56.66 Mn |
| Dec 31, 2024 | 55.03 Mn |
| Sep 30, 2024 | 56.51 Mn |
| Jun 30, 2024 | 55.16 Mn |
| Mar 31, 2024 | 51.81 Mn |
| Dec 31, 2023 | 43.95 Mn |
| Sep 30, 2023 | 50.94 Mn |
| Jun 30, 2023 | 36.52 Mn |
| Mar 31, 2023 | 36.48 Mn |
| Dec 31, 2022 | 36.33 Mn |
| Sep 30, 2022 | 36.35 Mn |
| Jun 30, 2022 | 36.29 Mn |
| Mar 31, 2022 | 36.27 Mn |
| Dec 31, 2021 | 36.19 Mn |
| Sep 30, 2021 | 36.22 Mn |